Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in CABG Surgery (DREAM)
NCT00524901Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2007
- Primary completion
- Jan 2011
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in coronary artery disease (CAD), sponsored by University Medical Center Groningen. Started Sep 2007; status: completed.
02
Drugs
epoetin alfa
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00524901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524901.